Award

Framework for the Provision of Dose Banded Products & Patient Specific Chemotherapy Services

  • University Hospitals of Derby and Burton NHS Foundation Trust

UK5: Transparency notice - Procurement Act 2023 - view information about notice types

Notice identifier: 2026/S 000-006485

Procurement identifier (OCID): ocds-h6vhtk-060e0f

Published 26 January 2026, 10:31am



Scope

Reference

D100/C358943

Description

Framework for the Provision of Dose Banded Products & Patient Specific Chemotherapy Services to member Trusts of the East Midlands Pharmacy Collaborative.

Commercial tool

Establishes a framework


Framework

Maximum percentage fee charged to suppliers

0%

Further information about fees

N.A

Justification for framework term over 4 years

The estimated revised spend for EMPC for this new Contract value now exceeds the Cabinet Office Spend Control Threshold of £20 million for a two-year framework period. This is due to the increase requirements for additional molecules across our member Trusts.

Under Cabinet Office Spend Control requirements, EMPC are required to submit a business case for approval prior to publishing the new tender.

The current contract is due to expire on 30 June 2026. To maintain continuity of patient care and ensure uninterrupted product and service delivery, EMPC will extend the existing agreements with current Awarded Suppliers beyond this date. New Procurement timescales will be communicated to the market as soon as possible.

It is anticipated the new Tender will be published in the summer of 2026 if spend control approval is given.

A UK 06 Contract Award and a UK 07 Contract Details Notice will be published on the Find a Tender portal.

Contracting authorities that may use the framework

Establishing party only


Contract 1. Contract Extension

Suppliers (3)

Contract value

  • £9,000,000 excluding VAT
  • £9,000,000 including VAT

Above the relevant threshold

Earliest date the contract will be signed

1 April 2026

Contract dates (estimated)

  • 1 July 2026 to 30 June 2027
  • Possible extension to 30 June 2028
  • 2 years

Description of possible extension:

Dependent on outcome of OBC and if a FBC is required for Spend Controls

Main procurement category

Goods

CPV classifications

  • 33600000 - Pharmaceutical products

Participation

Particular suitability

Small and medium-sized enterprises (SME)


Other information

Description of risks to contract performance

No risk to extending as Suppliers are known to the Trusts.

The risk is having no continuity of essential contract performance management and may mean that Trusts may have to find alternative sources of supply outside of Contract.

Conflicts assessment prepared/revised

Yes


Procedure

Procedure type

Direct award

Direct award justification

Switching to direct award

The estimated revised spend for EMPC for this new Contract value now exceeds the Cabinet Office Spend Control Threshold of £20 million for a two-year framework period. This is due to the increase requirements for additional molecules across our member Trusts.

Under Cabinet Office Spend Control requirements, EMPC are required to submit a business case for approval prior to publishing the new tender.

The current contract is due to expire on 30 June 2026. To maintain continuity of patient care and ensure uninterrupted product and service delivery, EMPC will extend the existing agreements with current Awarded Suppliers beyond this date. New Procurement timescales will be communicated to the market as soon as possible.

It is anticipated the new Tender will be published in the summer of 2026 if spend control approval is given.

A UK 06 Contract Award and a UK 07 Contract Details Notice will be published on the Find a Tender portal.


Suppliers

BATH ASU

  • Companies House: 05548345

Unit A15, Fiveways Light Ind Est, West Wells Road

Corsham

SN13 9RG

United Kingdom

Region: UKK15 - Wiltshire CC

Small or medium-sized enterprise (SME): No

Voluntary, community or social enterprise (VCSE): No

Contract 1. Contract Extension

Baxter Healthcare Limited

  • Companies House: 00461365

Wallingford Rd

Newbury

RG20 7QW

United Kingdom

Region: UKJ11 - Berkshire

Small or medium-sized enterprise (SME): No

Voluntary, community or social enterprise (VCSE): No

Contract 1. Contract Extension

ITH Pharma Ltd

  • Companies House: 06569105

Unit 4 Premiere Park

London

NW10 7NZ

United Kingdom

Region: UKI72 - Brent

Small or medium-sized enterprise (SME): Yes

Voluntary, community or social enterprise (VCSE): No

Contract 1. Contract Extension


Contracting authority

University Hospitals of Derby and Burton NHS Foundation Trust

  • Public Procurement Organisation Number: PQZD-7532-NDHL

Royal Derby Hospital, Uttoxeter Road

Derby

DE22 3NE

United Kingdom

Contact name: Andrew Wilson

Email: andrewwilson6@nhs.net

Website: https://www.uhdb.nhs.uk

Region: UKF11 - Derby

Organisation type: Public authority - central government